SG11202012582QA - Methods of producing recombinant proteins - Google Patents
Methods of producing recombinant proteinsInfo
- Publication number
- SG11202012582QA SG11202012582QA SG11202012582QA SG11202012582QA SG11202012582QA SG 11202012582Q A SG11202012582Q A SG 11202012582QA SG 11202012582Q A SG11202012582Q A SG 11202012582QA SG 11202012582Q A SG11202012582Q A SG 11202012582QA SG 11202012582Q A SG11202012582Q A SG 11202012582QA
- Authority
- SG
- Singapore
- Prior art keywords
- methods
- recombinant proteins
- producing recombinant
- producing
- proteins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/34—Sugars
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862693606P | 2018-07-03 | 2018-07-03 | |
| PCT/US2019/040298 WO2020010080A1 (fr) | 2018-07-03 | 2019-07-02 | Procédés de production de protéines recombinées |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202012582QA true SG11202012582QA (en) | 2021-01-28 |
Family
ID=67470657
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202012582QA SG11202012582QA (en) | 2018-07-03 | 2019-07-02 | Methods of producing recombinant proteins |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20210253996A1 (fr) |
| EP (2) | EP3818078B1 (fr) |
| JP (2) | JP7419273B2 (fr) |
| KR (1) | KR20210027427A (fr) |
| CN (1) | CN112839954A (fr) |
| AU (1) | AU2019299358A1 (fr) |
| BR (1) | BR112020025623A2 (fr) |
| CA (1) | CA3104684A1 (fr) |
| DK (1) | DK3818078T3 (fr) |
| EA (1) | EA202092904A1 (fr) |
| FI (1) | FI3818078T3 (fr) |
| IL (1) | IL279782A (fr) |
| LT (1) | LT3818078T (fr) |
| MX (1) | MX2020013633A (fr) |
| PL (1) | PL3818078T3 (fr) |
| PT (1) | PT3818078T (fr) |
| SG (1) | SG11202012582QA (fr) |
| WO (1) | WO2020010080A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023242238A1 (fr) * | 2022-06-15 | 2023-12-21 | UCB Biopharma SRL | Procédés de culture cellulaire |
| EP4339274A1 (fr) | 2022-09-13 | 2024-03-20 | Sartorius Stedim Biotech GmbH | Procédé de fonctionnement d'une installation de bioprocédé pour la production d'un bioproduit |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4515893A (en) | 1979-04-26 | 1985-05-07 | Ortho Pharmaceutical Corporation | Hybrid cell line for producing complement-fixing monoclonal antibody to human T cells |
| US5672347A (en) | 1984-07-05 | 1997-09-30 | Genentech, Inc. | Tumor necrosis factor antagonists and their use |
| IL85035A0 (en) | 1987-01-08 | 1988-06-30 | Int Genetic Eng | Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same |
| US5091313A (en) | 1988-08-05 | 1992-02-25 | Tanox Biosystems, Inc. | Antigenic epitopes of IgE present on B cell but not basophil surface |
| US5720937A (en) | 1988-01-12 | 1998-02-24 | Genentech, Inc. | In vivo tumor detection assay |
| EP0420937B1 (fr) | 1988-06-21 | 1994-11-09 | Genentech, Inc. | Compositions therapeutiques pour le traitement de l'infarctus du myocarde |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| DE122006000006I2 (de) | 1991-08-14 | 2011-06-16 | Genentech Inc | Veränderte Immunglobuline für spezifische FC-Epsilon Rezeptoren |
| MX9305070A (es) | 1992-08-21 | 1994-04-29 | Genentech Inc | Compocicion farmaceutica que contiene un antagonista de lfa-1 para el tratamiento de transtornos o desordenes mediados por el lfa-1 |
| US5736137A (en) | 1992-11-13 | 1998-04-07 | Idec Pharmaceuticals Corporation | Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
| WO1995016203A2 (fr) | 1993-12-10 | 1995-06-15 | Genentech, Inc. | Procedes pour diagnostiquer des allergies et pour selectionner des agents therapeutiques antiallergiques |
| ATE164079T1 (de) | 1994-01-18 | 1998-04-15 | Genentech Inc | Verfahren zur behandlung von parasitären infektionen unter verwendung von ige-antagonisten |
| US5677426A (en) | 1994-03-03 | 1997-10-14 | Genentech, Inc. | Anti-IL-8 antibody fragments |
| IL117645A (en) | 1995-03-30 | 2005-08-31 | Genentech Inc | Vascular endothelial cell growth factor antagonists for use as medicaments in the treatment of age-related macular degeneration |
| JPH11507535A (ja) | 1995-06-07 | 1999-07-06 | イムクローン システムズ インコーポレイテッド | 腫瘍の成長を抑制する抗体および抗体フラグメント類 |
| ATE222774T1 (de) | 1996-01-23 | 2002-09-15 | Genentech Inc | Antikörper gegen cd 18 zur verwendung gegen gehirnschlag |
| US7147851B1 (en) | 1996-08-15 | 2006-12-12 | Millennium Pharmaceuticals, Inc. | Humanized immunoglobulin reactive with α4β7 integrin |
| EP1516629B1 (fr) | 1996-11-27 | 2013-04-03 | Genentech, Inc. | Anticorps humanisés contre CD11a |
| SI1325932T1 (fr) | 1997-04-07 | 2005-08-31 | Genentech Inc | |
| ATE516354T1 (de) | 1997-05-15 | 2011-07-15 | Genentech Inc | Apo-2-rezeptor |
| US6946129B1 (en) | 1999-06-08 | 2005-09-20 | Seattle Genetics, Inc. | Recombinant anti-CD40 antibody and uses thereof |
| IL149116A0 (en) | 1999-10-29 | 2002-11-10 | Genentech Inc | Anti-prostate stem cell antigen (psca) antibody compositions and methods of use |
| TWI374935B (en) | 2004-08-27 | 2012-10-21 | Pfizer Ireland Pharmaceuticals | Production of α-abeta |
| NZ597334A (en) | 2006-09-13 | 2014-02-28 | Abbott Lab | Cell culture improvements |
| CN103443123B (zh) | 2011-02-07 | 2020-05-29 | 塞勒尼斯医疗控股公司 | 脂蛋白复合物及其制备和用途 |
| US9813410B2 (en) | 2014-06-26 | 2017-11-07 | Rakuten, Inc. | Information processing apparatus, information processing method, and information processing program |
-
2019
- 2019-07-02 PT PT197458458T patent/PT3818078T/pt unknown
- 2019-07-02 KR KR1020217003056A patent/KR20210027427A/ko unknown
- 2019-07-02 FI FIEP19745845.8T patent/FI3818078T3/fi active
- 2019-07-02 EA EA202092904A patent/EA202092904A1/ru unknown
- 2019-07-02 PL PL19745845.8T patent/PL3818078T3/pl unknown
- 2019-07-02 SG SG11202012582QA patent/SG11202012582QA/en unknown
- 2019-07-02 CA CA3104684A patent/CA3104684A1/fr active Pending
- 2019-07-02 AU AU2019299358A patent/AU2019299358A1/en active Pending
- 2019-07-02 EP EP19745845.8A patent/EP3818078B1/fr active Active
- 2019-07-02 LT LTEPPCT/US2019/040298T patent/LT3818078T/lt unknown
- 2019-07-02 JP JP2020573229A patent/JP7419273B2/ja active Active
- 2019-07-02 EP EP24153543.4A patent/EP4368699A2/fr active Pending
- 2019-07-02 MX MX2020013633A patent/MX2020013633A/es unknown
- 2019-07-02 CN CN201980044908.3A patent/CN112839954A/zh active Pending
- 2019-07-02 DK DK19745845.8T patent/DK3818078T3/da active
- 2019-07-02 BR BR112020025623-4A patent/BR112020025623A2/pt unknown
- 2019-07-02 WO PCT/US2019/040298 patent/WO2020010080A1/fr unknown
- 2019-07-02 US US17/252,163 patent/US20210253996A1/en active Pending
-
2020
- 2020-12-25 IL IL279782A patent/IL279782A/en unknown
-
2024
- 2024-01-10 JP JP2024001657A patent/JP2024050590A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DK3818078T3 (da) | 2024-05-21 |
| KR20210027427A (ko) | 2021-03-10 |
| AU2019299358A1 (en) | 2021-02-18 |
| LT3818078T (lt) | 2024-04-25 |
| WO2020010080A1 (fr) | 2020-01-09 |
| PL3818078T3 (pl) | 2024-04-29 |
| JP7419273B2 (ja) | 2024-01-22 |
| JP2021529527A (ja) | 2021-11-04 |
| BR112020025623A2 (pt) | 2021-03-23 |
| IL279782A (en) | 2021-03-01 |
| EP3818078B1 (fr) | 2024-02-28 |
| CA3104684A1 (fr) | 2020-01-09 |
| US20210253996A1 (en) | 2021-08-19 |
| EA202092904A1 (ru) | 2021-04-22 |
| FI3818078T3 (fi) | 2024-05-14 |
| CN112839954A (zh) | 2021-05-25 |
| EP4368699A2 (fr) | 2024-05-15 |
| MX2020013633A (es) | 2021-03-25 |
| PT3818078T (pt) | 2024-04-18 |
| JP2024050590A (ja) | 2024-04-10 |
| EP3818078A1 (fr) | 2021-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL281954A (en) | Heterodimeric chimeric proteins | |
| IL288205A (en) | Purification of fkpa and its uses for the production of recombinant polypeptides | |
| GB201419109D0 (en) | Incorporation of unnatural amino acids into proteins | |
| IL286745A (en) | Continuous production of recombinant proteins | |
| ZA202006604B (en) | Method for selection of high m6p recombinant proteins | |
| MA53498A (fr) | Production de protéines recombinantes | |
| IL276067A (en) | Production of glucagon peptides | |
| EP3592800A4 (fr) | Compositions et procédés de production de rendements sécrétés élevés de protéines recombinées | |
| EP3495491A4 (fr) | Procédé de production d'une protéine recombinante | |
| GB201806072D0 (en) | Methods of manufacture | |
| IL284026A (en) | Methods for producing heterodimeric antibodies | |
| EP3377633C0 (fr) | Production de protéines recombinantes | |
| IL279782A (en) | Methods for producing recombinant proteins | |
| EP3592762A4 (fr) | Compositions et procédés de production de rendements sécrétés élevés de protéines recombinées | |
| IL262544A (en) | A method for producing a recombinant protein | |
| HK1255456A1 (zh) | 含fc蛋白的表達 | |
| ZA202101433B (en) | An improved process for the preparation of recombinant lectin protein | |
| GB201805904D0 (en) | Methods of Manufacture | |
| EP3532618A4 (fr) | Polypeptide signal pour la sécrétion améliorée de protéine | |
| SG11202107697UA (en) | Method for producing recombinant protein | |
| EP3680343A4 (fr) | Procédé d'augmentation de la sécrétion de protéine recombinante | |
| SG11201708751RA (en) | Method of producing a recombinant protein | |
| IL256706B (en) | A method for making recombinant proteins | |
| IL256707B (en) | A method for the production of recombinant proteins | |
| HK1256714A1 (zh) | 製備治療性蛋白質的方法 |